Gilead adds to cell therapy portfolio with $8bn acquisition of Arcellx
By Catherine Eckford (European Pharmaceutical Review)
Leftover bread could support sustainable pharmaceutical manufacturing
By Catherine Eckford (European Pharmaceutical Review)
Daiichi Sankyo picks Dr John Tsai to head up R&D
By Catherine Eckford (European Pharmaceutical Review)
GSK wins dual EU approval for its ultra-long-acting biologic Exdensur
By Catherine Eckford (European Pharmaceutical Review)
Applying AI to enhance drug formulation and development
By Sanjay Konagurthu (Thermo Fisher Scientific)
Accelerating consistent, stable cell line development with targeted integration
By Fei Chen (WuXi Biologics), Hang Zhou (WuXi Biologics), Tao…






























